TW0006472004
TW0006472004
BORA PHARMACEUTICALS CO LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 19.014.169.000 | 17.426.624.000 | 9.1% |
| Cost of Revenue | 11.161.155.000 | 9.636.088.000 | 15.8% |
| Gross Profit | 7.853.014.000 | 7.790.536.000 | 0.8% |
| 4.557.725.000 | 4.082.536.000 | 11.6% | |
| Operating Income | 3.295.289.000 | 3.708.000.000 | 11.1% |
| Pretax Income | 5.277.888.000 | 5.223.172.000 | 1.0% |
| Net Income Common Stockholders | 2.981.311.000 | 3.852.515.000 | 22.6% |
| -- | -- | -- | |
| -- | -- | -- |